Why the study?
Do implantable cardioverter-defibrillators (ICDs) improve overall survival compared with pharmacologic therapy for secondary prevention of cardiac arrest in elderly patients?
Population
Elderly patients with malignant ventricular arrhythmias requiring secondary prevention of cardiac arrest
Comparison
Implantable cardioverter-defibrillators for… vs Pharmacologic therapy
Design
Review
Authors
Loading...
May support ICD consideration for secondary prevention in elderly patients; hypothesis-generating and requires prospective confirmation.
Do implantable cardioverter-defibrillators (ICDs) improve overall survival compared with pharmacologic therapy for secondary prevention of cardiac arrest in elderly patients?
ICD therapy for secondary prevention reduces all-cause mortality in the elderly and should not be withheld based on age alone.
Traub et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: